日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

水飞蓟宾抑制肿瘤细胞对尼达尼布的内在耐药性并增强其在肺癌中的临床活性

Joaquim Bosch-Barrera, Sara Verdura, José Carlos Ruffinelli, Enric Carcereny, Elia Sais, Elisabet Cuyàs, Ramon Palmero, Eugeni Lopez-Bonet, Alejandro Hernández-Martínez, Gloria Oliveras, Maria Buxó, Angel Izquierdo, Teresa Morán, Ernest Nadal, Javier A Menendez

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

白藜芦醇靶向 PD-L1 糖基化和二聚化以增强抗肿瘤 T 细胞免疫

Sara Verdura, Elisabet Cuyàs, Eric Cortada, Joan Brunet, Eugeni Lopez-Bonet, Begoña Martin-Castillo, Joaquim Bosch-Barrera, José Antonio Encinar, Javier A Menendez

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

新辅助二甲双胍联合全身治疗可降低残余乳腺癌的增殖能力

Lopez-Bonet, Eugeni; Buxó, Maria; Cuyàs, Elisabet; Pernas, Sonia; Dorca, Joan; Álvarez, Isabel; Martínez, Susana; Pérez-Garcia, Jose Manuel; Batista-López, Norberto; Rodríguez-Sánchez, César A; Amillano, Kepa; Domínguez, Severina; Luque, Maria; Morilla, Idoia; Stradella, Agostina; Viñas, Gemma; Cortés, Javier; Oliveras, Gloria; Meléndez, Cristina; Castillo, Laura; Verdura, Sara; Brunet, Joan; Joven, Jorge; Garcia, Margarita; Saidani, Samiha; Martin-Castillo, Begoña; Menendez, Javier A

Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate

线粒体自噬驱动的线粒体再生调控干细胞命运

Vazquez-Martin, Alejandro; Van den Haute, Chris; Cufí, Sílvia; Corominas-Faja, Bruna; Cuyàs, Elisabet; Lopez-Bonet, Eugeni; Rodriguez-Gallego, Esther; Fernández-Arroyo, Salvador; Joven, Jorge; Baekelandt, Veerle; Menendez, Javier A

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas

癌症干细胞驱动的曲妥珠单抗(赫赛汀)疗效:迈向临床HER2阳性乳腺癌的重新分类

Martin-Castillo, Begoña; Lopez-Bonet, Eugeni; Cuyàs, Elisabet; Viñas, Gemma; Pernas, Sonia; Dorca, Joan; Menendez, Javier A

Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin.

携带 PIK3CA 激活突变 H1047R 的对饮食限制有抵抗性的人类肿瘤对二甲双胍敏感。

Cufí Sílvia, Corominas-Faja Bruna, Lopez-Bonet Eugeni, Bonavia Rosa, Pernas Sonia, López Isabel Álvarez, Dorca Joan, Martínez Susana, López Norberto Batista, Fernández Severina Domínguez, Cuyàs Elisabet, Visa Joana, Rodríguez-Gallego Esther, Quirantes-Piné Rosa, Segura-Carretero Antonio, Joven Jorge, Martin-Castillo Begoña, Menendez Javier A

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency

二甲双胍可限制 iPS 细胞的致瘤性,而不会影响其多能性

Alejandro Vazquez-Martin, Sílvia Cufi, Eugeni Lopez-Bonet, Bruna Corominas-Faja, Cristina Oliveras-Ferraros, Begoña Martin-Castillo, Javier A Menendez